Wells Fargo Maintains Overweight on Inspire Medical Systems, Raises Price Target to $305
Wells Fargo analyst Larry Biegelsen maintains Inspire Medical Systems (NYSE:INSP) with a Overweight and raises the price target from $250 to $305.
SVB Leerink Maintains Outperform on Inspire Medical Systems, Raises Price Target to $325
SVB Leerink analyst Danielle Antalffy maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and raises the price target from $300 to $325.
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
Here's a roundup of top developments in the biotech space over the last 24 hours:
Earnings Scheduled For November 2, 2021
Companies Reporting Before The Bell
• Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion.
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.
Analyst Ratings For Inspire Medical Systems
Analysts have provided the following ratings for Inspire Medical Systems (NYSE:INSP) within the last quarter:
10 Biggest Price Target Changes For Friday
Telsey Advisory Group reduced the price target for NIKE, Inc. (NYSE: NKE) from $180 to $176. NIKE shares fell 4.6% to $152.26 in pre-market trading.
SVB Leerink Maintains Outperform on Inspire Medical Systems, Raises Price Target to $300
SVB Leerink analyst Richard Newitter maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and raises the price target from $265 to $300.
The Daily Biotech Pulse: Restricted Authorization For Pfizer’s COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 22)
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 26)